ArticleEuropean radiology2025
Intravoxel incoherent motion-derived histogram analysis for quantitative evaluation of tumor budding and prognostic stratification in rectal cancer.
Article in European radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Development and validation: a whole-tumor histogram model based on intravoxel incoherent motion diffusion-weighted imaging for diagnosing tumor deposits in rectal cancer.Abdominal radiology (New York) · 2026Article
- Clinical utility and reproducibility of intravoxel incoherent motion MRI in rectal cancer: a structured narrative review.Frontiers in medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
objectiveTo determine the value of intravoxel incoherent motion (IVIM) for quantitative tumor budding (TB) evaluation and prognostic stratification in patients with rectal cancer (RC). MATERIALS AND
methodsThis study enrolled 189 RC patients (training set 148, validation set 41) who underwent IVIM and were subsequently treated surgically within 2 weeks between January 2022 and April 2023. Hematoxylin-eosin staining was used for TB scoring. IVIM metrics were calculated on MRI images using biexponential fitting and histogram analysis. Differences in IVIM histogram metrics between the low-intermediate grade budding (Bd 1 + 2) and the high-grade budding (Bd 3) were analyzed. Multivariate logistic regression analysis was used to build the Combined model. The area under the receiver operating characteristic curve (AUC) was used to assess the diagnostic performance of the IVIM histogram metrics and the Combined model. Kaplan-Meier analysis was employed to estimate disease-free and overall survival rates for patients.
resultsMultivariate logistic analysis showed that the D_25th percentile, D_75th percentile, D_90th percentile, and D_95th percentile were independent predictors of Bd 3 (all p < 0.05). The Combined model incorporating these four factors had the best diagnostic performance, with the AUC, sensitivity, and specificity of 0.852, 73.02%, and 82.35% in the training set and 0.856, 75.00%, and 86.21% in the validation set. Furthermore, the score of the Combined model was significantly associated with worse 2-year overall survival (hazard ratio 6.804, 95% confidence interval 2.214 to 20.909, p = 0.001).
conclusionThe IVIM histogram metrics could distinguish different TB grades and be used as a preoperative risk stratification tool. KEY POINTS: Questions Does intravoxel incoherent motion based on histogram analysis predict tumor budding grades and its prognosis in patients with rectal cancer? Findings The histogram metrics of slow diffusion coefficient are an independent prediction factor of high-grade tumor budding and a risk factor of poor 2-year overall survival. Clinical relevance This combined model, based on slow diffusion coefficient, is a reliable tool for preoperative predicting 2-year overall survival in patients with rectal cancer, contributing to risk stratification and individual treatment.
Indexed as
Identifiers
40272490What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.